Milrinone Use in Persistent Pulmonary Hypertension of the Newborn
- 1 March 2020
- journal article
- Published by American Academy of Pediatrics (AAP) in NeoReviews
- Vol. 21 (3), e165-e178
- https://doi.org/10.1542/neo.21-3-e165
Abstract
Failure of the normal transition from in utero to ex utero physiology leads to “persistent” pulmonary hypertension of the newborn (PPHN). PPHN is frequently associated with low systemic blood pressure and low cardiac output because of increased right ventricular afterload and myocardial dysfunction. The general management of newborns with PPHN is geared toward maintenance of normothermia, normal serum electrolytes, normal intravascular volume, correction of acidosis, adequate sedation/analgesia, adequate ventilation and oxygenation with optimal lung recruitment, and avoidance of hyperoxia. Inotropic and vasoactive agents are commonly initiated early to increase cardiac output, maintain adequate systemic blood pressure, and enhance oxygen delivery to the tissue. Unfortunately, there is not much evidence on the choice, timing of initiation, dosing, monitoring, and titrating of vasoactive agents in this patient population. In this review, we will discuss the pathophysiology of PPHN and review the use of inotropic, lusitropic, and vasoactive agents in the management of PPHN, with particular attention to milrinone.Keywords
This publication has 50 references indexed in Scilit:
- Terlipressin as rescue therapy for refractory pulmonary hypertension in a neonate with a congenital diaphragmatic herniaJournal of Pediatric Surgery, 2011
- Neonatal pulmonary hypertensionPediatric Critical Care Medicine, 2010
- Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newbornPediatric Critical Care Medicine, 2009
- Population pharmacokinetics and dosing regimen design of milrinone in preterm infantsArchives of Disease in Childhood: Fetal & Neonatal, 2007
- Pilot study of milrinone for low systemic blood flow in very preterm infantsThe Journal of Pediatrics, 2006
- Neonatal Persistent Pulmonary Hypertension Treated with Milrinone: Four Case ReportsNeonatology, 2006
- Which inotrope for which baby?Archives of Disease in Childhood: Fetal & Neonatal, 2005
- Efficacy and Safety of Milrinone in Preventing Low Cardiac Output Syndrome in Infants and Children After Corrective Surgery for Congenital Heart DiseaseCirculation, 2003
- Inhaled Nitric Oxide and Gentle Ventilation in the Treatment of Pulmonary Hypertension of the Newborn — a Single-Center, 5-Year ExperienceJournal of Perinatology, 2002
- Dopamine effects on pulmonary artery pressure in hypotensive preterm infants with patent ductus arteriosusThe Journal of Pediatrics, 2002